An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants
Status:
Completed
Trial end date:
2017-11-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of taking multiple doses of BMS-986177
when aspirin is taken once-daily. Eligible participants will receive twice-daily doses of
BMS-986177 or placebo, with a once-daily dose of aspirin. The safety, tolerability and
movement of BMS-986177 into, through and out of the body (pharmacokinetics/PK) will be
assessed, as will the effect of BMS-986177 on the PK of aspirin.